Table 2.
Surgical procedure of patients with MHRD who underwent inverted ILM flap covering technique or inverted ILM flap insertion technique.
| ILM flap covering (n = 23) | ILM flap insertion (n = 25) | Total (n = 48) | P | |
|---|---|---|---|---|
| Duration of PPV course (min, mean ± SD) | 48.65 ± 10.18 | 49.80 ± 9.35 | 49.25 ± 9.67 | 0.686 |
| Use of PFO, n (%) | 11 (47.8) | 13 (52.0) | 24 (50.0) | 0.773 |
| Presence of attached posterior hyaloid or epiretinal membrane (present/absent), n (%) | 10 (43.5)/13 (56.5) | 11 (44.0)/14 (56.0) | 21 (43.8)/27 (56.3) | 0.971 |
| Combined cataract surgery, non-PEA/PEA + IOL/PEA only, n (%) | 5 (21.7)/6 (26.1)/12 (52.2) | 10 (40)/8 (32.0)/7 (28.0) | 15 (31.3)/14 (29.2)/19 (39.6) | 0.203 |
| Duration of SO before prim surg removal (months, mean ± SD) | 4.65 ± 1.70 | 4.36 ± 1.66 | 4.50 ± 1.66 | 0.415† |
| Follow-up time (months, mean ± SD) | 21.52 ± 4.11 | 22.40 ± 4.23 | 21.98 ± 4.15 | 0.470 |
*Fisher’s exact probability test.
†Mann–Whitney U test.
PPV pars planar vitrectomy, PFO perfluoro-n-octane, PEA phacoemulsification and aspiration, IOL intraocular lens, SO silicone oil.